Zacks Investment Management’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-89,117
Closed -$543K 595
2020
Q3
$543K Sell
89,117
-3,493
-4% -$26.7K 0.01% 396
2020
Q2
$822K Buy
+92,610
New +$798K 0.02% 334

Other funds holding NPTN

Zacks Investment Management's NPTN Position: Q4 2020 in Review

Zacks Investment Management sold out of NEOPHOTONICS CORP (NPTN) in Q4 2020, closing a stake of 89,117 shares — an estimated $543K sold.

Zacks Investment Management first reported a position in NPTN in Q2 2020 and held it in 2 quarters. The position peaked at $822K in Q2 2020. 138 funds tracked by Wall St. Rank hold NPTN as of Q4 2020.

  • Zacks Investment Management reported no remaining NEOPHOTONICS CORP position as of Q4 2020 after selling out during the quarter.
  • Zacks Investment Management sold 89,117 NEOPHOTONICS CORP shares in Q4 2020, an estimated $543K.
  • Zacks Investment Management first reported a position in NEOPHOTONICS CORP in Q2 2020 and held it in 2 quarters.
  • Zacks Investment Management's NEOPHOTONICS CORP position peaked at $822K in Q2 2020.
  • 138 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q4 2020.

Based on Zacks Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.